In the current issue of Psychotherapy and Psychosomatics, researchers failed to find evidence for the use of aripiprazole (Abilify®) in depression. In this study the investigators assessed the efficacy of low-dose aripiprazole added to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) with inadequate response to prior ADT.
The number of people living on their own has doubled over the last three decades to one in three in the UK and US. New research published in BioMed Central’s open access journal BMC Public Health shows that the risk of depression, measured by people taking antidepressants, is almost 80% higher for those living alone […]
Over a 10-year period, spending for Medicaid-enrolled patients with depression increased substantially but only minimal improvements in quality of care were observed, according to a report in the December issue of Archives of General Psychiatry, one of the JAMA/Archives journals. The study was carried out by Catherine A. Fullerton, M.D., M.P.H., of Harvard Medical School […]
Patients with major depression who fail to see improvement after taking an antidepressant often have their initial medication switched or combined with a second drug. Many clinicians weigh the possibility of adverse side effects when deciding between strategies. New research in the latest issue of General Hospital Psychiatry now suggests one strategy may not be […]
A study by researchers at the University of Mississippi Medical Center (UMMC) and the University of California, San Francisco (UCSF) shows that rats given a popularly prescribed antidepressant during development exhibit brain abnormalities and behaviors characteristic of autism spectrum disorders. The findings suggest that taking a certain class of antidepressants known as selective serotonin reuptake […]
Prolonged exposure therapy, cognitive therapy, and delayed prolonged exposure therapy, appear to reduce posttraumatic stress disorder symptoms in patients who have experienced a recent traumatic event, according to a report published Online First by Archives of General Psychiatry, one of the JAMA/Archives journals. The study was conducted by Arieh Y. Shalev, M.D., and colleagues from Hadassah […]
About half of Medicaid-covered children and adolescents in Ohio who are in treatment for depression complete their first three months of prescribed antidepressants, and only one-fifth complete the recommended minimum six-month course of drugs to treat depression, new research suggests. Among those at the highest risk for not completing treatment are adolescents – as opposed […]
Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving researchers at The University of Nottingham has found. The research, published on bmj.com, discovered that selective serotonin reuptake inhibitors (SSRIs) are more strongly associated with […]
Recent Comments